ALLR / Allarity Therapeutics, Inc. - Kepemilikan Institusional - Pembeli

Allarity Therapeutics, Inc.

Institusi dan Kepemilikan Dana - Pembeli

Pemegang saham utama yang telah membuka posisi baru di Allarity Therapeutics, Inc. termasuk Vanguard Capital Management Llc, Vanguard Fiduciary Trust Co, Jones Financial Companies Lllp, dan Caitong International Asset Management Co., Ltd .

Halaman ini menunjukkan perubahan struktur kepemilikan berdasarkan daftar institusi, dana, dan pemegang saham utama yang telah meningkatkan kepemilikannya atau membuka posisi baru pada periode pelaporan terakhir. Baris hijau menunjukkan posisi baru. Klik tautannya ikon untuk melihat riwayat transaksi lengkap.

Upgrade untuk membuka data premium.

Tanggal Berkas Sumber Investor Jenis Harga Rata-rata
(Perkiraan)
Saham Δ Saham
(%)
Dilaporkan
Nilai
($1000)
Δ Nilai
(%)
Alokasi Portofolio
(%)
2026-05-11 13F Citigroup Inc 7.766 8
2026-05-08 13F Vanguard Fiduciary Trust Co This fund is a listed as child fund of Vanguard Group Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value 74.913 82
2026-05-15 13F Geode Capital Management, Llc 190.393 21,55 208 22,49
2026-05-14 13F Northern Trust Corp 48.103 66,20 52 67,74
2026-05-15 13F Jones Financial Companies Lllp 1 0
2026-05-15 13F/A Vanguard Capital Management Llc 171.795 187
2026-05-11 13F Caitong International Asset Management Co., Ltd 1 0
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista